Literature DB >> 2411769

Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation.

J Tremblay, B Lachance, P Hamet.   

Abstract

We have previously reported that the cAMP-specific phosphodiesterase activity in washed rat platelets is increased by a short exposure of platelet suspension to PGE1 and 1-methyl-3-isobutyl-xanthine (MIX). We report here that the incubation of washed platelets with forskolin resulted in an increase in the binding of cGMP and the activity of cGMP-phosphodiesterase as well as that of cAMP-specific phosphodiesterase. As for PGE1, MIX potentiated the stimulatory effect of forskolin. The maximal activation of phosphodiesterases by forskolin and MIX occurred after 30 sec of incubation of platelets (with a slow decline thereafter). The activation of phosphodiesterases in intact platelets by forskolin occurred in parallel with the dissociation of a cAMP-dependent protein kinase. Prior incubation of a platelet supernatant with Mg-ATP and cAMP had only a slight effect on cAMP- or cGMP-phosphodiesterase activities, but the presence of MIX during the prior incubation, followed by appropriate dilution, greatly enhanced the activity of the two phosphodiesterases. The phosphodiesterase activation in vitro was inhibited by a non-hydrolysable analogue of ATP, AMP-PNP. Since the cGMP-binding phosphodiesterase activity is enhanced by the catalytic subunit of cAMP-dependent protein kinase in the presence of MIX and absence of cAMP, the effect of MIX cannot be explained in terms of the protection of cAMP from hydrolysis. It is possible that the xanthine increases the susceptibility of the cAMP-specific and cGMP-binding phosphodiesterases to phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411769

Source DB:  PubMed          Journal:  J Cyclic Nucleotide Protein Phosphor Res        ISSN: 0746-3898


  6 in total

Review 1.  Regulating cellular cyclic adenosine monophosphate: "Sources," "sinks," and now, "tunable valves".

Authors:  Michael Getz; Padmini Rangamani; Pradipta Ghosh
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-04-23

2.  Immunological identification of the major platelet low-Km cAMP phosphodiesterase: probable target for anti-thrombotic agents.

Authors:  C H Macphee; S A Harrison; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity.

Authors:  P G Grant; A F Mannarino; R W Colman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Production of an antiserum against cyclic nucleotide phosphodiesterase and its use for the immunocytochemical demonstration of this enzyme in rat cerebellum.

Authors:  G Poeggel; H Luppa; W Ludwig; P Borneleit
Journal:  Histochemistry       Date:  1988

Review 5.  Histochemistry of nucleotidyl cyclases and cyclic nucleotide phosphodiesterases.

Authors:  G Poeggel; H Luppa
Journal:  Histochem J       Date:  1988-05

6.  A predictive computational model reveals that GIV/girdin serves as a tunable valve for EGFR-stimulated cyclic AMP signals.

Authors:  Michael Getz; Lee Swanson; Debashish Sahoo; Pradipta Ghosh; Padmini Rangamani
Journal:  Mol Biol Cell       Date:  2019-04-24       Impact factor: 4.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.